Studies in chicken liver cancer, mouse myoblasts, pancreatic carcinoma, and human liver cells have noted that quercetin acts as a METTL3 inhibitor, decreasing m6A levels [41,42,43]. Here, METTL3 is linked to exocrine pancreatic carcinoma.